-
公开(公告)号:WO2008106058A2
公开(公告)日:2008-09-04
申请号:PCT/US2008002395
申请日:2008-02-20
Applicant: VERTEX PHARMA , FARMER LUC , BETHIEL RANDY SCOTT , JACOBS DYLAN , PERNI ROBERT B , MAXWELL JOHN , COTTRELL KEVIN , HALAS SUMMER
Inventor: FARMER LUC , BETHIEL RANDY SCOTT , JACOBS DYLAN , PERNI ROBERT B , MAXWELL JOHN , COTTRELL KEVIN , HALAS SUMMER
CPC classification number: C07D487/10 , C07D498/10
Abstract: The present invention relates to compounds that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The invention further relates to compositions comprising these compounds either for ex vivo use or for administration to a patient suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a patient by administering a composition comprising a compound of this invention.
Abstract translation: 本发明涉及抑制丝氨酸蛋白酶活性,特别是丙型肝炎病毒NS3-NS4A蛋白酶活性的化合物。 因此,它们通过干扰丙型肝炎病毒的生命周期起作用,也可用作抗病毒剂。 本发明还涉及包含这些化合物的组合物,用于离体使用或给予患有HCV感染的患者。 本发明还涉及通过施用包含本发明化合物的组合物来治疗患者HCV感染的方法。
-
公开(公告)号:NZ579295A
公开(公告)日:2012-03-30
申请号:NZ57929508
申请日:2008-02-20
Applicant: VERTEX PHARMA
Inventor: FARMER LUC , BETHIEL RANDY SCOTT , JACOBS DYLAN , PERNI ROBERT B , MAXWELL JOHN , COTTRELL KEVIN , HALAS SUMMER
IPC: C07D487/10 , A61K31/407 , A61P31/12 , C07D498/10
Abstract: Disclosed are spiro compounds of formula I or pharmaceutically acceptable salts thereof, and methods for their synthesis. Specific examples of compounds of formula I include: (5S,8S)-7-((S)-2-(2-cyclohexylacetamido)-3,3-dimethylbutanoyl)-N-((S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl)-2-oxo-3-phenyl-1-oxa-3,7-diazaspiro[4.4]nonane-8-carboxamide, (5R,8S)-7-((S)-2-(2-cyclohexylacetamido)-3,3-dimethylbutanoyl)-N-((S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl)-2-oxo-3-phenyl-1-oxa-3,7-diazaspiro[4.4]nonane-8-carboxamide, Cyclopentyl-(S)-1-((3S,5R)-3-((S)-1-(cyclopropylamino)-1,2-dioxohexan-3-ylcarbamoyl)-8-oxo-7-phenyl-2,7-diazaspiro[4.4]nonan-2-yl)-3,3-dimethyl-1-oxobutan-2-ylcarbamate, and Cyclopentyl (S)-1-((3S,5S)-3-((S)-1-(cyclopropylamino)-1,2-dioxohexan-3-ylcarbamoyl)-8-oxo-7-phenyl-2,7-diazaspiro[4.4]nonan-2-yl)-3,3-dimethyl-1-oxobutan-2-ylcarbamate. Also disclosed is the use of compounds of formula I for treating a hepatitis C virus (HCV) infection.
-
公开(公告)号:AU2008219704A1
公开(公告)日:2008-09-04
申请号:AU2008219704
申请日:2008-02-20
Applicant: VERTEX PHARMA
Inventor: HALAS SUMMER , PERNI ROBERT B , BETHIEL RANDY SCOTT , JACOBS DYLAN , MAXWELL JOHN , COTTRELL KEVIN , FARMER LUC
IPC: C07D487/10 , A61K31/407 , A61P31/12 , C07D498/10
Abstract: The present invention relates to compounds that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The invention further relates to compositions comprising these compounds either for ex vivo use or for administration to a patient suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a patient by administering a composition comprising a compound of this invention.
-
公开(公告)号:MX2009009176A
公开(公告)日:2009-09-28
申请号:MX2009009176
申请日:2008-02-20
Applicant: VERTEX PHARMA
Inventor: FARMER LUC , PERNI ROBERT B , MAXWELL JOHN , BETHIEL RANDY SCOTT , JACOBS DYLAN , COTTRELL KEVIN , HALAS SUMMER
IPC: C07D487/10 , A61K31/00 , A61P31/12 , C07D498/10
Abstract: La presente invención se refiere a compuestos que inhiben la actividad de serina-proteasas, particularmente la actividad de la proteasa NS3-NS4A del virus de hepatitis C. como tales, actúan al interferir con el ciclo de vida del virus de hepatitis C y también son útiles como agentes antivirales. La invención se refiere adicionalmente a composiciones que comprenden estos compuestos ya sea para el uso ex vivo o para la administración de un paciente que padece de infección de HCV. La invención también se refiere a métodos para tratar una infección de HCV en el paciente al administrar una composición que comprende un compuesto de esta invención.
-
公开(公告)号:CA2679426A1
公开(公告)日:2008-09-04
申请号:CA2679426
申请日:2008-02-20
Applicant: VERTEX PHARMA
Inventor: BETHIEL RANDY SCOTT , FARMER LUC , COTTRELL KEVIN , HALAS SUMMER , JACOBS DYLAN , PERNI ROBERT B , MAXWELL JOHN
IPC: C07D487/10 , A61K31/407 , A61P31/12 , C07D498/10
Abstract: The present invention relates to compounds that inhibit serine protease a ctivity, particularly the activity of hepatitis C virus NS3-NS4A protease. A s such, they act by interfering with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The invention further relates to c ompositions comprising these compounds either for ex vivo use or for adminis tration to a patient suffering from HCV infection. The invention also relate s to methods of treating an HCV infection in a patient by administering a co mposition comprising a compound of this invention.
-
-
-
-